PCOS name change to PMOS to lead to a holistic approach, involve more disciplines: Prof. Terhi Piltonen
Professor Terhi Piltonen on why PCOS is being renamed PMOS and what the change could mean for how the condition is diagnosed and treated
In May, the Endocrine Society renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), as reported by Prof. Terhi Piltonen, president of the International Androgen Excess and Polycystic Ovary Syndrome Society. The change comes from a consensus article published in the Lancet, led by Prof. Helena J. Teede.
Piltonen explained that the renaming process took 14 years and involved input from 56 societies, 100 individuals, patient organizations, and healthcare professionals. The aim was to broaden the understanding of the condition beyond just ovaries and cysts, focusing on how it impacts mood, psychology, metabolism, and menstrual cycles.
Piltonen hopes the new name will encourage a holistic approach to treatment, involving more disciplines in research and patient care. The name change also has implications for existing treatment protocols, as researchers will use both PCOS and PMOS codes for the next three years before fully transitioning. The funding for research on PMOS is currently not proportional to its prevalence, but Piltonen hopes for more grants and industry involvement in addressing this condition.
Written by urgent.news from The Hindu - Sci-Tech's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
